CRWD Stage 2 Uptrend Intact, but Price below 50-Day MA as Base Forms

CRWD daily stock chart with 10, 20, 50, 150 and 200-day moving averages, volume and RS line versus SPY — CANSLIM Research

CRWD is holding its Stage 2 advance, trading above a rising 30-week moving average with the 150-day and 200-day MAs in a bullish alignment. However, the stock is currently 14.7% off its 52-week high and has slipped below its 50-day MA, while a shallow two-week base has formed near the highs. The overall sentiment is constructive, but traders are awaiting a confirmed breakout above the 225.53 pivot to signal renewed upside momentum.

As of 2026-08-25 · Close $192.4

Stage 2 (Advancing) — Price holding above a rising 30-week MA — uptrend intact (30-week MA 6-week slope: 11.01%)

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.